The Magnum Group

The Leader In Vision Care Business Development

TEL: 415.453.5550 |
1000 Fourth Street, Suite 225 San Rafael, CA 94901 USA


Randy McDonald

Randy McDonald—Founder and President of The Magnum Group, Inc.

Mr. McDonald is the founder and president of The Magnum Group, Inc. (Magnum)—the largest business development firm in the ophthalmic market. Since 1995, Magnum has specialized in mergers & acquisitions, licensing, financing and Strategic Alliances. Mr. McDonald has over 30 years of experience in ophthalmic sales, marketing, business development, operations and financing with both Fortune 500 and start-up organizations. He has specific product knowledge, senior-level industry contacts and experience in spectacle, contact and intraocular lenses, refractive surgery, glaucoma, retina, capital/diagnostic equipment, bio-pharmaceuticals and e-commerce services.

Prior to Magnum, Mr. McDonald served as Executive Vice President of DAC Vision, a $50 million company, and the largest US manufacturer of consumable products and supplies for ophthalmic lens fabrication. Previously, he was the first Chief Operating Officer of InnoTech, Inc., an ophthalmic lens manufacturer, which was sold to Johnson & Johnson and is currently owned by Essilor. Mr. McDonald has also held various sales and marketing positions with Bausch & Lomb, Dow Corning, Quantum Labs and Hydrocurve (now part of Alcon).

Mr. McDonald is a co-founder of six start ups, including, InnoTech (see above), Quest Vision Technologies, Inc., (an Accommodating Intraocular Lens “IOL” company, which was sold to AMO in 2005); PowerVision, Inc. (a micro-fluidics adjustable Accommodating IOL company, that is Venture funded); and Vision Solutions Technologies, Inc. (a Macular Degeneration IOL Company).

Mr. McDonald holds B.S. degrees in Political Science and History from Kansas State University, has written numerous published articles and spoken at a variety of ophthalmic meetings. He is also a founding member of the American European College of Ophthalmic Surgery and is a member of Vision Council.

Back to top

Nancy Clary—Accounting Manager

Nancy Clary is the Accounting Manager for The Magnum Group, Inc. She is in charge of managing all of Magnum’s accounting and daily business functions.

Before joining Magnum, Nancy was a Vice President at Laughing Stock Records, (a.k.a. Dr. Elmo of Grandma Got Run Over by a Reindeer fame) where she worked on a broad range of accounting and financial roles over 16 years. She started her career at Phoenix Leasing, following that she held various positions at American Express Life Assurance and The Meridian Fund.

When not at work, she can be found running the Dipsea Trail or refereeing a high school basketball game. She is married to a retired police officer and has two sons in college. Nancy holds a Bachelor of Arts degree in Business Economics from University of California, Santa Barbara.

Back to top

Denise Belli—Administrative Services Manager

Denise Belli has over 20 years of ophthalmic administrative and executive assistant level experience. As the Administrative Services Manager for The Magnum Group, Inc., she oversees all office, administrative and travel-related support to the Managing Director and President. She also provides customer service support to Magnum’s Clients and Affiliates.

Before joining Magnum in January 2015, she held manager, coordinator and administrative level positions at the SF Association Management Services, which is a subsidiary of the American Academy of Ophthalmology (AAO).  Prior to the AAO, she spent six years with the Department of Treasury, Internal Revenue Service, in both San Francisco and Washington, DC. In her spare time, Denise loves vegetable gardening, watching professional athletics and spending time with her husband and family, particularly watching her son’s play sports.

Back to top


Philip M. Buscemi, OD

Philip M. Buscemi, OD

Dr. Buscemi has over 30 years experience in the ophthalmic industry as an owner/clinician; creating and managing the research and development of diagnostic instruments and software; as a GM or a Director of ophthalmic companies; managing US business development for a multi-national company; and organizing and running International Distributors meetings. Dr. Buscemi's unique blend of business and clinical experience brings tremendous value to his clients.

Dr. Buscemi is an expert business and technical consultant to the ophthalmic industry. He has management capability in R&D, corporate management, marketing, sales, and is able to present complex information to experienced and non-experienced audiences. He is a highly imaginative thinker & able to solve complex technical and business challenges, along with being a very successful optometric practitioner.

Dr. Buscemi earned his BS, OD (with High Honors) from the Pennsylvania College of Optometry; earned his BS Pre Med (with Honors) from the North Carolina State University.

Dr. Buscemi's other interests include creating a working flight/racing simulator using a projection dome; he has created a private cooking group taught by a classically trained chefs; and is a current member of the Charleston Offshore Racing Association, CORA, Crew a J-130.

Back to top

Janet L. Conway, Ph. D., Wyoming Ophthalmic Consulting

Head of Wyoming Ophthalmic Consulting, which provides R&D guidance to ophthalmic start-up organizations and due-diligence, risk assessment, and strategic planning for more developed companies.

Dr. Conway brings 25 years of experience in the ophthalmic pharmaceutical, drug delivery and device sector, serving in a variety of roles from R&D, to product development to licensing. Dr. Conway provides scientific, pre-clinical and clinical assistance and analysis to The Magnum Group. Previously, Dr. Conway was Director of Licensing and Development at Pfizer, Executive Director of Ophthalmology Licensing at Pharmacia, Director of Global Business Development for Johnson & Johnson’s Vision Care Franchise, Vice President of Product Development and one of four founders of M6 Pharmaceuticals. She held similar positions at VimRx Pharmaceuticals, Olympus Corporation (Medical Device Division), and at Johnson & Johnson’s ophthalmic pharmaceutical and medical device company, IOLAB. Prior to J & J, Dr. Conway was a Senior Scientist in Allergan’s Discovery Research organization;

Dr. Conway received BA and MA degrees from Northeastern University, earned a Ph. D. from the Massachusetts Institute of Technology in visual neurophysiology and completed a post-doctoral fellowship in neurochemistry at The University of California, Irvine. She serves on the Board of Directors of Aerie Pharmaceuticals. Dr. Conway and her husband, ophthalmologist K. Buol Heslin, MD, live on a ranch in Alta, Wyoming raising organic grass-fed cattle.

Back to top

Judy F. Gordon, D.V.M., ClinReg Consulting Services,

Founder, President and brings over 20 years of experience in pharmaceuticals, biologics, and medical devices to her consulting practice. A clinical and regulatory consultant since 1998, Dr. Gordon was with Chiron Vision, a division of Chiron Corporation, from the company’s founding in 1986 through its successful acquisition by Bausch & Lomb in 1997. At Chiron Vision, Dr. Gordon held several roles including Sr. Vice President of R&D and as V.P. of Scientific Affairs, with responsibility for product development, clinical research, regulatory affairs, and regulatory compliance.

In her consulting practice, Dr. Gordon has been involved in the development, clinical and regulatory activities for a broad range of products including injectable polymers for tissue bulking, refractive surgery devices, CAD systems for tumor detection, coils for aneurysm treatment, intracranial stents for stroke prevention, breast biopsy devices, intraocular drug delivery systems for treatment of macular degeneration and diabetic retinopathy, coronary atherectomy systems, and multiple other products representing novel technology.

Dr. Gordon has taken multiple PMAs and NDAs through the FDA review process, and has directed large-scale clinical trials of both devices and pharmaceutical products. In total, Dr. Gordon has prepared all or part of 16 successful PMA applications for novel devices. She served as the industry representative to FDA’s Ophthalmic Devices Advisory Panel, chaired an industry-FDA working group on guidance documents for clinical trials of refractive surgery lasers, and as the industry representative to the Mediation Dispute Panel of the Center for Devices and Radiologic Health (CDRH).

Back to top

James M. Grootegoed, Optical Technology Consultant

Mr. Grootegoed provides market research and analysis on new product and technologies for Magnum’s Optical Technologies Division. Mr. Grootegoed is a 30-year industry veteran in wholesale lab, sales, marketing, administration and corporate management. He retired in 2001 and is a consultant to The Magnum Group, Inc. as well as other ophthalmic companies. From 1982 until December 2001, Mr. Grootegoed served in a variety of positions with Walman Optical Company, most recently as Executive Vice President, and Board Member. Walman is the second largest wholesale laboratory in the USA with 21 branches in 19 states. During his tenure, annual sales grew from $56 million to $138 million. Prior to Walman, Mr. Grootegoed worked for Bausch & Lomb from 1979 to 1982 in product management and then as Director of Marketing for the Optical Laboratory Division. Mr. Grootegoed entered the ophthalmic industry in 1974 as a sales representative with Titmus Optical and was promoted to Manager of Distribution, Customer Service and Product Manager.

Mr. Grootegoed is a founder and former board member of the Polycarbonate Council and the AR (Anti Reflective) Council. He is currently the Technology Editor for a publication that focuses on lens processing, and has written many articles and spoken at numerous industry meetings and conferences. Mr. Grootegoed is a graduate of California State University, Los Angeles, CA.

Back to top

Dave Harmon, Market

Founder, President and manages the leading source of market information on the ophthalmic surgical industry. Market Scope follows companies, technologies, regulatory issues, patents, providers, surgeons, procedure volumes, market share, and pricing. Because the Company focuses its efforts on the ophthalmic market, they are able to bring perspective and context to the latest industry information. The Company’s products include newsletters, reports, surveys, geographic analysis, custom research and analysis. Market Scope’s clients include the leading companies in the industry, investment analysts, surgeons, and optometrists.

Mr. Harmon has almost 25 years’ experience in the ophthalmic industry and has been writing and publishing newsletters and reports on the refractive industry since 1996. Through his extensive industry experience and his contacts in the business of refractive surgery, Mr. Harmon has become a leading expert in all business and technical aspects of the refractive industry.

Mr. Harmon’s ophthalmology experience began in 1984 at Alcon Laboratories, where he served in several capacities including three years as Manager of Business Planning and Acquisitions for the Surgical Division and five years as General Manager of the Alcon Systems Division. His education background includes a Bachelors of Science in Business Administration with an Accounting major from Texas Tech University and a Masters of Science in Finance from the University of Texas at Dallas.

Back to top

Paul Karpecki, OD, Karpecki Resource Group

Founder, President, and leads a consulting company that provides product awareness and clinical education to optometry for a select group of ophthalmic partners, through various educational media. For over 14 years, Dr. Karpecki has partnered with ophthalmic companies to create key strategic marketing messages and science-based educational initiatives that have allowed numerous companies to achieve great success in the vast optometric market for their products. He also currently works at the Koffler Vision Group in Cornea services and heads the department of Ocular Surface Disease Research.

Dr. Karpecki is currently the Chair of the Refractive Surgery Advisory Board to the American Optometric Association, Chair of the Topical Interest Group in Refractive Surgery, co-chair of the ASCRS Task Force on the Integrated Eyecare Delivery System and serves on the AOA Congress Education Committee. A noted educator and author, Dr. Karpecki presently serves on seven professional journal editorial boards. He was previously the president of the Optometric Council on Refractive Technology,

Dr. Karpecki has lectured in over 400 symposia, covering four continents, and is the first optometrist to be invited to both the Delphi International Society at Wilmer- John’s Hopkins that includes the top 25 dry eye experts in the world, and the National Eye Institute’s dry eye committee. This was a task force established by the U.S. Department of Health and Human Services to better understand and treat dry eye disease in women. Doctor Karpecki’s interest also include education in the area of new advances in ophthalmic technology ranging from optometric education around cataract surgery options for patients to innovative diagnostics, therapeutics and disease management technologies.

Dr. Karpecki is a member of the Court of Master Sommeliers and his wine knowledge in the area of nutrition and understanding wine has allowed a number of his client companies to add another educational dimension via wine tasting.

Dr. Karpecki graduated from Indiana University School of Optometry and completed a fellowship in Cornea and Refractive Surgery at Hunkeler Eye Centers in Kansas City in affiliation with the Pennsylvania College of Optometry in 1994.

Back to top

Michael Lachman, Lachman Consulting,

Founder, President and brings 25 years of experience to investment research and analysis, new business development, marketing, and engineering for corporate clients.

Previously Mr. Lachman was a Partner, Managing Director, and equity research analyst with Think Equity Partners, a growth-focused investment bank based in San Francisco. At Think Equity, Mr. Lachman’s research was focused primarily on ophthalmology, orthopedics, and specialty cardiology. Before that, Mr. Lachman was a healthcare analyst on the buy-side with SAC Capital Advisors and Jurika & Voyles. His first experience in equity research was as a medical device analyst with Hambrecht & Quist, where he received a #1 ranking in medical industry stock picking in the Wall Street Journal All-Star Analyst Survey.

Mr. Lachman also brings 12 years of medical device industry experience. He worked for five years in business development for the Ethicon Endo-Surgery division of Johnson & Johnson. Previously, Mr. Lachman spent seven years with Baxter Healthcare Corporation, working in both research & development and product management, with a focus on implantable surgical products.

Mr. Lachman holds an M.B.A. (with concentrations in marketing and finance) from Northwestern University's Kellogg School of Management. He also holds an M.S. in Mechanical Engineering from Stanford University, and a B.S. in Aeronautical Engineering with highest honors from the University of Illinois.

Back to top

Shareef Mahdavi, SM2

Founder and President, and is based in the San Francisco Bay Area. Mr. Mahdavi has over 20 years of experience in medical devices and has held senior marketing and sales roles with Advanced Medical Optics, Carl Zeiss-Meditec, and Glaxo SmithKline; he led the marketing team at VISX during the launch of the laser used in LASIK, which today is the top elective surgical procedure performed in the US.

Mr. Mahdavi provides expertise in increasing consumer demand for new medical technologies in elective (self-pay) procedures. He works with leading manufacturers, VC/Incubators, and physicians. He is a sought after lecturer for medical conferences and manufacturer user group events. His clients are innovators in refractive surgery, aesthetics, eye disease, sleep/snoring, and cosmetic dentistry. Mr. Mahdavi is also a certified expert on the Experience Economy, one of only ten individuals to earn that designation under the tutelage of authors Pine and Gilmore.

Back to top

Brendan B. Sheil, Affiliate

Mr. Sheil has over 20 years’ experience in sales and marketing in Ophthalmology developing relationships and overseeing the sales and strategic development of various ophthalmic products worldwide. Since 2009, he founded and is president of Synergy Ophthalmic Solutions, LLC, a Midwest based ophthalmic device distributor and consulting firm. Previously Mr. Sheil was Vice President of Commercial Operations of the Americas for Bausch + Lomb Surgical. Prior to this role he was Executive Director of Bausch and Lomb's U.S. Refractive Business. In his senior roles, he developed various go to market strategies and successfully implemented these strategies with internal and external sales operation teams. He has been a recipient of various accolades for his achievements and is a speaker on product implementation strategies and practice development.

Mr. Sheil holds a Bachelor's Degree in Business from Iowa State University and sits in an advisory role for various established and start-up ophthalmic companies.

Anthony Sine, Affiliate

Mr. Sine has more than 15 years of legal, transaction and product development experience in the Life Sciences market with specific expertise in Ophthalmology, Plastic Surgery and Dermatology. He works with companies across life-stages, from ideation to Fortune 500 companies, and across a range of transactions from mergers and acquisitions, licenses and partnerships, joint development, co-promotions and other strategic collaborations to venture capital and private and public equity and debt financings. Mr. Sine also has significant experience in product development, regulatory processes and commercial roll-outs, international corporate governance and deep industry contacts.

Mr. Sine also frequently participates with national and local organizations on business matters including by acting as a guest panelist for Kellogg's (Northwestern University) Physician CEO 2016 program, acting as emcee for Cornell University's 2016 Health-Tech Hackathon and emceeing the Orange County Summit on Aesthetics & Dermatology in 2014 and 2015.

Back to top

Terry Thomas, Thomas Resource Group,

Mr. Thomas has been a retained executive search consultant for over 25 years. He has also been an operating executive with three Fortune 500 companies and a management consultant.

In 1986 Mr. Thomas established the Thomas Resource Group, Inc., a retained executive search firm focused on senior executive positions in the life science area with particular emphasis in medical device and biopharmaceutical companies. Mr. Thomas has successfully conducted searches for early-stage and start-up companies as well as larger corporations.

Mr. Thomas entered the executive search profession with Korn/Ferry International where he was a Vice President and Partner in the San Francisco office. He successfully conducted searches for senior marketing, financial and operations positions. Mr. Thomas has also been a management consultant to several entrepreneurial enterprises.

Prior to entering the executive search profession, Mr. Thomas held operating management positions with several major U.S. corporations. He was Director of Marketing, the senior executive for sales and marketing, for McKesson Corporation’s international pharmaceutical business.

Mr. Thomas was also with Baxter Healthcare Corporation where he held several management positions in the U.S. and Colombia, South America prior to being promoted to General Manager with full P & L responsibility for Baxter’s business in Central America. Mr. Thomas started his career with the Coca-Cola Company as District Manager. He served as a counterintelligence officer in the U.S. Army (Vietnam).

Mr. Thomas is a graduate of Stanford University and earned an MBA from the Kellogg School of Management at Northwestern University and speaks fluent Spanish. He formerly served on the board of directors of TMMS, which supports the Vision Beckman Center at UCSF.

Back to top


Contact Information

View Larger Map

Get in Touch

The Magnum Group, Inc.
1000 Fourth Street, Suite 225
San Rafael, CA 94901 USA
TEL: 415.453.5550
FAX: 415.453.5522


Back to top